Pfizer’s rare heart disease drug succeeds in late-stage study

(Reuters) Pfizer Inc’s experimental drug to treat a rare and fatal disease linked to heart failure reduced deaths and need for hospitalizations in a late-stage study. FILE PHOTO: A company logo is seen at a Pfizer office in Dublin, Ireland November 24, 2015. REUTERS/Cathal McNaughton The company’s clinical study investigated the efficacy, safety and [ ] The post Pfizer s rare heart disease drug succeeds in late-stage study appeared first on Health and Fitness.
http://bit.ly/2GsnOXb